Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Claratyne RediTabs (General sale) Loratadine 10mg Orodispersible tablet Bayer New Zealand Limited Catalent Pharma Solutions Limited, Swindon, United Kingdom
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Claratyne RediTabs (Pharmacy only) Loratadine 10mg Orodispersible tablet Bayer New Zealand Limited Catalent Pharma Solutions Limited, Swindon, United Kingdom
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Tecentriq Atezolizumab 1200mg Concentrate for infusion Roche Products (NZ) Limited Roche Diagnostics GmbH, Mannheim, Germany F Hoffmann-La Roche Limited, Kaiseraugst, Switzerland
|
Dated this 11th day of February 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).